Total Revenue
Becton, Dickinson and Company Total Revenue decreased by 10.2% to $4.71B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.2%, from $4.48B to $4.71B. Over 4 years (FY 2021 to FY 2025), Total Revenue shows an upward trend with a 3.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates growing market demand or successful price increases, while a decrease suggests market saturation or competitive pressure.
Detailed definition
The total amount of income generated by the sale of goods or services related to the company's primary operations. For a...
Peer comparison
Peer technology firms typically report this as Net Sales or Total Revenue, reflecting the scale of their market reach.
total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.61B | $4.30B | $4.72B | $4.75B | $4.64B | $4.76B | $4.59B | $4.82B | $4.88B | $5.09B | $4.71B | $5.05B | $4.99B | $5.44B | $5.17B | $4.48B | $5.51B | $6.68B | $5.25B | $4.71B |
| QoQ Change | — | -6.6% | +9.7% | +0.7% | -2.3% | +2.6% | -3.7% | +5.1% | +1.2% | +4.3% | -7.5% | +7.2% | -1.1% | +9.0% | -4.9% | -13.3% | +23.0% | +21.3% | -21.4% | -10.2% |
| YoY Change | — | — | — | — | +0.7% | +10.7% | -2.8% | +1.5% | +5.1% | +6.8% | +2.6% | +4.6% | +2.3% | +6.9% | +9.8% | -11.2% | +10.4% | +22.9% | +1.6% | +5.2% |
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| BioPharma Systems | $4.99B | $5.44B | — | — | $5.51B | $6.68B | $5.25B | $4.71B |
| Connected Care | $4.99B | $5.44B | — | — | $5.51B | $6.68B | $5.25B | $4.71B |
| Interventional | $4.99B | $5.44B | $5.17B | $4.48B | $5.51B | $6.68B | $5.25B | $4.71B |
| Life Sciences | $4.99B | $5.44B | $5.17B | $4.48B | $5.51B | $6.68B | $5.25B | $4.71B |
| Medical | $4.99B | $5.44B | $5.17B | $4.48B | $5.51B | $6.68B | $5.25B | $4.71B |
| Medical Essentials | $4.99B | $5.44B | — | — | $5.51B | $6.68B | $5.25B | $4.71B |
| Total | $4.99B | $5.44B | $5.17B | $4.48B | $5.51B | $6.68B | $5.25B | $4.71B |
BioPharma Systems, Connected Care, Interventional, Life Sciences, Medical, Medical Essentials were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Geographic Breakdown — EMEA
| Segment | Q3 '21 | Q3 '22 | Q3 '23 | Q3 '24 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|
| EMEA | $4.30B | $4.76B | $5.09B | $5.44B | $6.68B | $5.25B | $4.71B |
| Greater Asia | $4.30B | $4.76B | $5.09B | $5.44B | $6.68B | $5.25B | $4.71B |
| Other | $4.30B | $4.76B | $5.09B | $5.44B | $6.68B | $5.25B | $4.71B |
| Total | $4.30B | $4.76B | $5.09B | $5.44B | $6.68B | $5.25B | $4.71B |
EMEA, Greater Asia, Other were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Geographic Breakdown — International
| Segment | Q4 '23 | Q1 '24 | Q2 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| International | $4.71B | $5.05B | $4.99B | $5.17B | $4.48B | $5.51B | $5.25B | $4.71B |
| Total | $4.71B | $5.05B | $4.99B | $5.17B | $4.48B | $5.51B | $5.25B | $4.71B |
International was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
Total Revenue at Other Companies
Frequently Asked Questions
- What is Becton, Dickinson and Company's total revenue?
- Becton, Dickinson and Company (BDX) reported total revenue of $4.71B in Q1 2026.
- How has Becton, Dickinson and Company's total revenue changed year-over-year?
- Becton, Dickinson and Company's total revenue increased by 5.2% year-over-year, from $4.48B to $4.71B.
- What is the long-term trend for Becton, Dickinson and Company's total revenue?
- Over 4 years (2021 to 2025), Becton, Dickinson and Company's total revenue has grown at a 3.4% compound annual growth rate (CAGR), from $19.13B to $21.84B.
- What does total revenue mean?
- The total amount of money a company brings in from selling its products and services.